Given that hyperuricemia is the second most prevalent metabolic disorder after diabetes, the increased expression of HMGCS2 in hyperuricemic mice may indicate its potential role in hyperuricemia-induced oxidative stress and mitochondrial dysfunction, ultimately leading to cardiac dysfunction. The gene discussed is HMGCS2; the disease is metabolic disease.